326 related articles for article (PubMed ID: 15191349)
1. The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels.
Diamanti-Kandarakis E; Palioniko G; Alexandraki K; Bergiele A; Koutsouba T; Bartzis M
Eur J Endocrinol; 2004 Jun; 150(6):793-8. PubMed ID: 15191349
[TBL] [Abstract][Full Text] [Related]
2. The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.
Lin S; Huiya Z; Bo L; Wei W; Yongmei G
Endocrine; 2009 Dec; 36(3):503-9. PubMed ID: 19856137
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome.
Sun L; Lv H; Wei W; Zhang D; Guan Y
J Endocrinol Invest; 2010 Feb; 33(2):77-82. PubMed ID: 19636212
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.
Glueck CJ; Sieve L; Zhu B; Wang P
Metabolism; 2006 Mar; 55(3):345-52. PubMed ID: 16483878
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.
Lee YH; Song GG
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():8-14. PubMed ID: 24439532
[TBL] [Abstract][Full Text] [Related]
6. [Reproductive problems in women with PCOS, the impact of PAL-1 CARRIERS OF 4G PAI -1 polymorphism and BMI].
Komsa-Penkova R; Golemanov G; Georgieva G; Slavov N; Popovski K; Ivanov P; Kovacheva K; Atanasova M; Blajev A
Akush Ginekol (Sofiia); 2014; 53(5):3-9. PubMed ID: 25558663
[TBL] [Abstract][Full Text] [Related]
7. [Reproductive problems in women with PCOS, the impact of PAI-1 carriers of 4G PAI-1 polymorphism and BMI].
Komsa-Penkova R; Golemanov G; Georgieva G; Popovski K; Slavov N; Ivanov P; Kovacheva K; Atanasova M; Blajev A
Akush Ginekol (Sofiia); 2014; 53(6):15-21. PubMed ID: 25672133
[TBL] [Abstract][Full Text] [Related]
8. The effect of plasminogen activator inhibitor-1 gene 4G/5G polymorphism on glucose and lipid metabolisms in Turkish obese children.
Kinik ST; Ataç FB; Verdi H; Cetintaş S; Sahin FI; Ozbek N
Clin Endocrinol (Oxf); 2005 May; 62(5):607-10. PubMed ID: 15853833
[TBL] [Abstract][Full Text] [Related]
9. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between 4G and 5G genetypes distribution of plasminogen activator inhibitor-1 gene polymorphism in its promoter region with polycystic ovarian syndrome].
Zhao JL; Chen ZJ; Zhao YR; Zhao LX; Wang LC; Tang R; Ma ZX
Zhonghua Fu Chan Ke Za Zhi; 2005 Aug; 40(8):528-31. PubMed ID: 16202290
[TBL] [Abstract][Full Text] [Related]
11. Family-based analysis of -675 4G/5G polymorphism in the PAI-1 gene of polycystic ovary syndrome in Chinese population.
Song X; Ge L; Wang D; Li L; Ma D; Li X; Song X
J Obstet Gynaecol; 2022 Oct; 42(7):3304-3308. PubMed ID: 36065507
[TBL] [Abstract][Full Text] [Related]
12. Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndrome.
Sales MF; Sóter MO; Candido AL; Fernandes AP; Oliveira FR; Ferreira AC; Sousa MO; Ferreira CN; Gomes KB
Gynecol Endocrinol; 2013 Oct; 29(10):936-9. PubMed ID: 23898913
[TBL] [Abstract][Full Text] [Related]
13. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study.
Festa A; D'Agostino R; Rich SS; Jenny NS; Tracy RP; Haffner SM
Circulation; 2003 May; 107(19):2422-7. PubMed ID: 12719278
[TBL] [Abstract][Full Text] [Related]
14. PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample.
Meigs JB; Dupuis J; Liu C; O'Donnell CJ; Fox CS; Kathiresan S; Gabriel SB; Larson MG; Yang Q; Herbert AG; Wilson PW; Feng D; Tofler GH; Cupples LA
Obesity (Silver Spring); 2006 May; 14(5):753-8. PubMed ID: 16855181
[TBL] [Abstract][Full Text] [Related]
15. The -675 4G/5G polymorphism in the PAI-1 gene may not contribute to the risk of PCOS.
Zhang TT; Yuan L; Yang YM; Ren Y
Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2326-31. PubMed ID: 25219833
[TBL] [Abstract][Full Text] [Related]
16. 4G/5G polymorphism of PAI-1 gene and Alu-repeat I/D polymorphism of TPA gene in Turkish patients with polycystic ovary syndrome.
Karadeniz M; Erdogan M; Berdeli A; Saygili F; Yilmaz C
J Assist Reprod Genet; 2007 Sep; 24(9):412-8. PubMed ID: 17661167
[TBL] [Abstract][Full Text] [Related]
17. Diabetic retinopathy, promoter (4G/5G) polymorphism of PAI-1 gene, and PAI-1 activity in Pima Indians with type 2 diabetes.
Nagi DK; McCormack LJ; Mohamed-Ali V; Yudkin JS; Knowler WC; Grant PJ
Diabetes Care; 1997 Aug; 20(8):1304-9. PubMed ID: 9250459
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism (-675 4G/5G) associated with obesity and vascular risk in children.
Berberoğlu M; Evliyaoğlu O; Adiyaman P; Ocal G; Ulukol B; Simşek F; Siklar Z; Törel A; Ozel D; Akar N
J Pediatr Endocrinol Metab; 2006 May; 19(5):741-8. PubMed ID: 16789641
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease.
Grancha S; Estellés A; Tormo G; Falco C; Gilabert J; España F; Cano A; Segui R; Aznar J
Thromb Haemost; 1999 Apr; 81(4):516-21. PubMed ID: 10235431
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism and polycystic ovary syndrome.
Kilicci C; Bayram B; Ozkurt M; Onlu H; Erkasap N; Mutlu F
Genet Test Mol Biomarkers; 2011; 15(7-8):565-7. PubMed ID: 21413876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
